EichorEICHOR
Study identifier: NCT06251323 Synced from ClinicalTrials.gov · August 07, 2026
● Study status: RecruitingiPATH

Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

Condition: Diabetes Mellitus, Type 2  ·  Sponsor: Stanford University

PhaseNA
Planned participants119680
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYesCheck eligibility criteria ↓
Where4 locations · 2 countries

Interested? Contact the study team ↓

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

Sixteen institutions will be selected from a HRSA uniform data system and have data collected for up to 3 years. Eight institutions will begin the iPATH practice transformation during year one, the other eight institutions will begin iPATH in year two. FQHC administrators, clinicians and staff will be enrolled to participate in the iPATH transformation in their clinic and will participate in qualitative interviews. Patient HbA1c data from the clinics will be collected for comparative data analysis during each year of the study.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

There is no obligation to join — the study team can answer your questions about taking part.

Always discuss trial participation with your own doctor first.

Full eligibility criteria (exactly as the study team wrote them)

Inclusion Criteria: * Two largest clinic sites in multi-clinic FQHCs operating in or near Massachusetts, Ohio, California, Puerto Rico * We will prioritize FQHCs performing in the lower half of the distribution for A1c control, as these FQHCs have greater room for improvement. Exclusion Criteria: * FQHCs that have a patient population comprised of more than 80% children * FQHCs that have a patient population multiplied by the FQHC's diabetes prevalence in the lowest 10% of all the clinics * FQHCs that have fewer than 5,000 or more than 50,000 patients.

Reproduced word-for-word from the public registry record — the study team can answer questions about it.

Locations (4)

Board of Trustees of the Leland Stanford Junior UniversityStanford, California, United StatesRecruiting
President and Fellows of Harvard College, T.H. Chan SchoolBoston, Massachusetts, United StatesRecruiting
The Ohio State UniversityColumbus, Ohio, United StatesRecruiting
Impactivo, LLC.San Juan, Puerto Rico, Puerto RicoRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →